Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Really? This stock was once 500$ a share? This seeking alpha article says so...Explains how Thermodox came into being and failed the first phase III but was adjusted and found success with a new approach.
Best
insert-text-here.
Gene Simmons lets it slip about the NYSE listing for Invictus strategies in a couple of places:
8:20 mark in video
Newbies??? Most recent information regarding Invictus. Due Diligence here:
Gene has got to go...Complain at this link:
He can't even get the URL correct??? On the money show? WTF! Look...maybe it will help and maybe it won't, but I wrote Invictus with the following contact and pleaded with them to examine the blogs and assess the damage this idiot is doing to our image. It might help, I was polite and courteous and professional and expressed real concern. Try the link. Its quick and easy.
http://invictus-md.com/contact/
NNT
Here is the Maricann Group Document Link...
https://webfiles.thecse.com/CSE_Form_10_-_Notice_of_Proposed_Transaction_Tycona.pdf?xPmNobO1_cOS9Cd9X5oKn9muj2Z0ceTQ
If he is just one stoner dude he sure is commanding high fees from more than on Canadian LP
CH
Not a stoner dude..maybe a guru.
I am NipNapTappy on stockhouse. I found a document that shows that Maricann just threw a chunk of money at Tycona as well(July 18th 2018)...follow my last posts over there for a trail that leads us closer to the truth.
http://www.stockhouse.com/companies/bullboard?symbol=ivitf&postid=28418841
NipNapTappy
CannabidioHead minus THC
Plus, check this link 1/2 million followers...
https://www.facebook.com/MassRoots/
Thats the meat on the bone I am talking about...its not over yet.
CH
Scam? or just poor decision making?
There is a big difference between a scam and poor decision making. Their is evidence of this company being a going concern on several websites that show traffic and utilization of those services. I don't think its a scam, I think its the result of a bunch of kids running a business. Hopefully this new decision will have some results. There is still meat on the bone here.....Canada going legal is going bring a lot more dispensaries online. If they are successful in signing existing and new ones it could be a step in a new direction.
MHO only...I am in now and I have bought and sold them before.
Its a big risk...what penny stock isn't?
CH
https://www.prnewswire.com/news-releases/massroots-launches-revamped-dispensary-portal-capable-of-serving-2-400-licensed-dispensaries-in-key-cannabis-markets-300669153.html
With Canada coming online and Issac's very public wing clipping maybe he will do something right....
CH
I don't know..something might be up..
Only 1/4 of the listed dispensaries (2400)=600x(the lowest fee)420=$252,000 a month. Thats a couple of million a year right there... The highest fee is $1,000. With Canada and hundreds more dispensaries coming online...could be juicy. That is if anyone will buy into the dicketrich bylines after his past performance. The current offerings(dilution) have given the company one last lifeline. Debt is currently in hand.. Issac has been stung and scrutinized and had a microscope shoved up his A$$. He hangs on toatal financial ruin if they fail this time. They are in new offices, an entire country is going live for weed just north of the border and they have a new plan. Can they execute? After review of the app despite the bugs I saw a community that loved the app and wanted to continue with it if improvements were continuing.... The ball is in Issac's court if he will just take it.
Extremely risky! I am in for $10,000... I love a good turnaround story.
Oh...I don't know...they have done some things.
They are one of the few licensed producers with a production and sales license for both dried flower and oils.
https://www.canada.ca/en/health-canada/services/drugs-medication/cannabis/licensed-producers/authorized-licensed-producers-medical-purposes.html
They have produced revenue,
https://www.greenmarketreport.com/portfolios/green-market-report/
They are in the company of some big names that were recently given supply agreements with the Canadian AGLC.
https://mjbizdaily.com/alberta-announces-agreements-with-13-canadian-cultivation-firms/
I get being pissed off about getting in early and getting shafted out of your money...been there...but they do have some money and they are in the game.
NNT
The Offering
S-1/a
The following summary contains basic information about the offering and the securities being registered hereunder and is not intended to be complete. It does not contain all the information that is important to you. For a more complete understanding of the securities we are offering, please refer to the sections of this prospectus titled “Description of Capital Stock.”
Securities Being Registered: 93,522,930 common stock.
Common Stock Outstanding Before the Offering:
587,497,236
Common Stock Outstanding After the Offering:
680,620,166
Use of Proceeds:The stock offered by this prospectus will be sold by the selling stockholders. We will not receive any proceeds from the sale of stock by the selling stockholder. However, we will receive proceeds from the sale of stock of our common stock to Kodiak under the Purchase Agreement, and upon the exercise of warrants held by Kodiak and the other selling stockholders. These proceeds would be used for general working capital purposes and for the expansion of Green Leaf’s cultivation facilities.
Risk Factors: An investment in our securities involves a high degree of risk and could result in the loss of your entire investment. Prior to making an investment decision, you should carefully consider all of the information in this prospectus and, in particular, you should evaluate the risk factors set forth under the caption “Risk Factors” beginning on page 4 of this prospectus.
OTCQB Symbol: PNTV
Newbies go here for DD....
http://invictus-md.com/category/investor-relations/
CH
Newbies check out this entire video. IVITF showcased in the second half of the video.
News Statement Out....
Newbs watch this video...the second half describes IVITF
The last word we heard in case ya wanna know....
INVICTUS MD STRATEGIES CORP. (TSXV: IMH; OTC: IVITF; FRA: 8IS1), through its interests in two Access to Cannabis for Medical Purposes Regulations ("ACMPR") license holders, its wholly-owned subsidiary Acreage Pharms Ltd. ("Acreage Pharms") and its one-third interest in AB Laboratories Inc. ("AB Labs"), continues to execute plans that will achieve production capacity of 6,000 kg commencing January 2018, several months before Canada expects cannabis to become recreationally legal. Total current annual production capacity at both locations is approximately 1,500 kg.
As announced on October 27, 2017, Health Canada had removed previously disclosed production capacity restrictions at both Acreage Pharms and AB Labs.
Update on Sales Approval
Both Acreage Pharms and AB Labs have submitted formal requests to Health Canada to amend its License to allow for the sale and distribution of medical cannabis. The issuance of the Amendment is subject to, among other things, a regulatory inspection of Acreage Pharms' and AB Labs' production facilities and cannot be guaranteed by the Company. However, the Company is confident that both facilities are compliant with all necessary requirements, that they will pass the required inspection, and that the Amendment will be issued in due course. The Pre-Sales License Inspection is the last step prior to the issuance of a Sales License under the ACMPR.
Update on Production
Acreage Pharms and AB Labs facility are currently at full production with a total combined capacity of approximately 1,500 kg annually.
Acreage Pharms recently completed its 6th harvest, and the yield increased by 30% over the prior harvest from the same room as a result of improved plant spacing and activation of the nutrient delivery system. The facility continues to grow completely pesticide free and the purpose built facility is out performing management's expectations for Good Production Practices and over all production values.
Update on Construction
Acreage Pharms is on schedule to complete its 32,000 square foot (phase 2) expansion by January 2018. Once completed total production capacity of Acreage Pharms is expected to reach 5,000 kg annually.
Management commentary
"I am extremely pleased that our operational activities are unfolding according to plan as well as our aggressive development strategy aimed at creating Canada's Cannabis Company," said Dan Kriznic, Chairman & CEO, of Invictus MD. "The issuance of the sales and distribution Amendment to Acreage Pharms and AB Labs cultivation license under the ACMPR will be a significant value catalyst for our shareholders. Additionally I can report that Invictus MD's balance sheet remains very strong; it has minimal debt and the approximate $26 million cash in the treasury has been earmarked for expanding its canopy footprint on its 250 acres of property with a goal to produce 15,000 kg per annum, which would make Invictus MD a top producer under the ACMPR. Our production will satisfy the significant demand in Canada for high quality, standardized, pesticide free product for the current medical cannabis market and the recreational market that will begin mid 2018."
About Invictus MD Strategies Corp.
Invictus MD Strategies Corp. is focused on two main verticals within the Canadian cannabis sector, namely the Licensed Producers under the ACMPR, being its 100% investment in Acreage Pharms Ltd., located in West-Central Alberta, and 33.3% investment AB Laboratories Inc., located near Hamilton, Ontario. Combined the two licenses expect to have run-rate production capacity of 6,000 kg commencing January 2018. Invictus MD is currently fully funded to expand operations at its two ACMPR licensees to approximately 150,000 sq. ft., which would net approximately 20,000 kg per annum. In addition to ACMPR licenses the Company has an 82.5% investment in Future Harvest Development Ltd. a Fertilizer and Nutrients manufacturer based in Kelowna, British Columbia.
Go here for original article:
https://www.equities.com/news/invictus-md-imh-ivitf-provides-update-on-acmpr-sales-license-amendment-as-it-prepares-for-legalization
C
Article previously linked looks like a mistake....
I cannot find any of the inside sellers names linked with Invictus...they are all names of sellers connected to Camden Property Trust.
I think the author of that article has made a mistake....
C
Insider selling before sales license is granted??? Why?
http://normanobserver.com/honeywell-international-lifted-its-camden-ppty-tr-cpt-stake-shorts-at-invictus-md-strategies-corporation-ord-ivitf-raised-by-880/
C
Is this true??? 800& increase in short interest and insider selling...
Shorts at INVICTUS MD STRATEGIES CORPORATION ORD (IVITF) Raised By 880%
December 26, 2017 - By Nellie Frank
INVICTUS MD STRATEGIES CORPORATION ORD (OTCMKTS:IVITF) had an increase of 880% in short interest. IVITF’s SI was 9,800 shares in December as released by FINRA. Its up 880% from 1,000 shares previously. The stock increased 3.71% or $0.041 during the last trading session, reaching $1.149. About shares traded. Invictus MD Strategies Corp. (OTCMKTS:IVITF) has 0.00% since December 26, 2016 and is . It has underperformed by 16.70% the S&P500.
Invictus MD Strategies Corp. produces, distributes, and sells cannabis and related products in Canada. The company has market cap of $92.18 million. It offers medical-grade marijuana for patients and adult users. It currently has negative earnings. The firm also makes and supplies hydroponics and fertilizers.
Since August 7, 2017, it had 0 insider buys, and 7 insider sales for $20.51 million activity. Shares for $5.14M were sold by ODEN D KEITH on Friday, December 8. Sengelmann William W. sold $458,418 worth of stock or 5,085 shares. 11,788 Camden Property Trust (NYSE:CPT) shares with value of $1.06M were sold by Jessett Alexander J.. 3,234 shares were sold by MCGUIRE WILLIAM B, worth $290,318. 52,247 shares were sold by CAMPO RICHARD J, worth $4.82M. The insider STEWART H MALCOLM sold 11,174 shares worth $1.00 million.
Offering officially closed...netted 42$ million...
https://www.prnewswire.com/news-releases/total-market-capitalization-of-all-cryptocurrencies-is-now-above-600-billion-665668603.html
CH
Nice little analysis if you have not seen it.....
Newbies...now is the time to buy. See presentation from today HERE:
https://www.slideshare.net/RedChip/interpace-diagnostics-group-presentation-84027729
CH
Invictus Strategies MD close to receiving Sales License.
https://www.equities.com/news/invictus-md-imh-ivitf-provides-update-on-acmpr-sales-license-amendment-as-it-prepares-for-legalization
http://invictus-md.com/wp-content/uploads/InvictusMD-20171023.pdf
Investors are catching on to this company....
Low Market Cap
Low outstanding share count compared to other competitors
Only LP to issue a dividend
Fully funded expansion projects
Read and invest...
CH
There are quite a few followers on this board as well....cross posting could help our cause. Good luck to all.....
https://www.stockhouse.com/companies/bullboard?symbol=c.imh
CH
This company is simply positioned better than 9/10ths of the weed stocks I can find anywhere....and at a bargain price.
See:
http://ir.baystreet.ca/article.aspx?id=673
CH
Wow...people just don't get it. This company is one of the best marijuana deals going. Two AMPCR licenses in Canada, 250 acres of land, pre-funded expansions in progress and 28 million dollars in cash. Canada set to install national legalization. 80 million shares outstanding. If you screwed up on the 2014 American Green Rush, here is your chance to get into the Canadian Market early.
GLTA
For those who are not familiar with Invictus MD Strategies Corp., it is focused on three main verticals within the burgeoning Canadian cannabis sector: Licensed Producers under the Access to Cannabis for Medical Purposes Regulations (ACMPR) located in both Alberta and Ontario, including Acreage Pharms Ltd. and AB Laboratories Inc.; fertilizer and nutrients through Future Harvest Development Ltd.; and Cannabis Data and Delivery, with its wholly owned subsidiary Poda Technologies Ltd. Invictus MD targets small and mid-size companies with proven brands, strong customer focus, and significant growth potential. Invictus directs the strategy towards profitability and growth for each of their portfolio companies. They assist the companies with business process integration and by structuring and deploying proper capital to support sustained growth.
In our last review of Invictus MD Strategies Corp we outlined the pending bought deal private placement (the “Offering”), with Canaccord Genuity Corp., Eventus Capital Corp., Echelon Wealth Partners Inc., GMP Securities L.P. and PI Financial Corp. On May 24, 2017 the Company announced the closing of the private placement for aggregate gross proceeds of $25,008,750. Net proceeds from the Offering will be used for expansion plans for the Company’s assets and for general working capital purposes. As compensation, the Underwriters received a commission of 5% of the gross proceeds and a corporate finance fee of 5% of the gross proceeds.
On May 29, 2017, Invictus MD today unveiled their new responsive website, invictus-md.com. The new site features a more vibrant, attractive and compelling design that showcases Invictus MD’s unique personality. Larry Heinzlmeir, Vice President of Marketing and Communication commented:
“We also wanted to amplify the value that we deliver to our investors at large, both verbally and visually–to better communicate to all of our audiences. Today’s launch marks the beginning of a new era. It’s fresher, stronger, and more modern. It represents the optimism we all feel about how the future of the cannabis sector can contribute to society. Our new verbal and visual identity signifies that we’re transforming as an organization.”
Invictus MD Strategies Corp announced on June 23, 2017 its inclusion in the Horizon Medical Marijuana Life Sciences ETF (TSX:HMMJ) (“HMMJ ETF”). HMMJ ETF is the first ETF to offer direct exposure to North American-listed stocks that operate in the legal medical cannabis industry. Horizon Medical Marijuana Life Sciences offers investors direct exposure to North American-listed stocks that are involved with biopharmaceuticals, medical manufacturing, distribution, bio-products, and other businesses ancillary to the marijuana industry. Invictus MD joins the 19 other constituents. Only stocks that meet minimum asset and liquidity thresholds are qualified for inclusion in the index, and no single stock may exceed 10% of the weight of the Index when rebalanced.
Invictus MD Strategies Corp’s 33% owned AB Labs announced on July 13, 2017 that has completed its first harvest, and anticipates a monthly harvest moving forward. These activities should begin generating significant revenue for the company moving into the second half of the year, which will scale up as the company increases production capacity over time. Management anticipates about 250 kilograms of production in 2017 before scaling up to 1,000 kilograms in future years.
AB Ventures — a subsidiary formed to develop a second licensed expansion facility in Hamilton, Ontario — is forging ahead with planning its Phase I expansion. The initial fully-funded $5.5 million expansion will be a 21,000-square foot purpose built facility capable of producing 3,000 kilograms per year. Management plans on completing this initial phase by the end of the year with plans to build an additional 21,000 square foot building envelope.
Acreage Pharms received a development permit for Phase II and has broken ground for the 27,800-square foot purpose built, multiple room production facility. The contracts and supplies necessary to complete the project have been scheduled and the company is prepared to invest $6 million toward the cost of constructing the production facility. The Phase III expansion will be a 76,750-square foot facility capable of producing 9,210 kilograms per year.
Read this one nice!!!
http://ir.baystreet.ca/article.aspx?id=673
The Best Kept Secret Of The Marijuana Boom
July 19, 2017 - By: Baystreet Staff
This little-known marijuana company is the only real entry point into the multi-billion-dollar Canadian pot market, and it's also the first marijuana company to pay a dividend to its shareholders.
Pot stocks were already skyrocketing—in some cases beyond 1700%--in anticipation that the Canadian government would put legislation on the table to legalize marijuana for recreational use in April.
That's already happened, and now stocks are going wild because it should all be legal by July 1st, 2018. This is the making of a multi-billion-dollar market overnight.
And this company could be the way in ...
Meet Invictus MD (TSX:IMH.V; OTC:IVITF)—a small-cap that has redefined savvy in this sector and will be walking with the jolly green giants by this time next year—when high valuations will slam doors shut and only billionaires will emerge.
The Fast-Track to Profits—The Lucrative Pot Pre-Approval
In what will prove to be the biggest multi-decade opportunity for investors, Invictus has already won pre-approval by the Canadian health authority to produce 15 strains of marijuana.
And this is only one of many firsts for this small-cap.
Right out of the gate, Invictus MD, owner of two of only 50 licenses, has demonstrated that it will lead the way. And it's cashed up and already generating dividends—a feat unheard of in the pot industry.
That's why it's called 'Canada's Cannabis Company'—it's already cemented market share for medical marijuana use, and now it's one of the first in and ready to fill the supply gap for a massive recreational push.
It's also the first licensed medical marijuana company to pay a dividend to shareholders, and with its strains reaching into everything from pain management, cancer, epilepsy, anxiety and – most lucratively of all—recreation, the sky is the limit here.
Supply Deficit Looming—This is Bigger Than Beer
We're now just shy of a year away from the start date of legal recreational use, and there are already predictions of a looming supply shortage.
The industry is scrambling to add greater capacity once these legal barriers are tossed aside.
Deloitte estimates this industry could be worth a whopping $22.6 billion annually. That's more than the combined sales of beer, wine and spirits.
We're going to be playing some serious catch-up, which is a producer's dream.
- Legalizing recreational marijuana could result in demand of about 400,000 kilograms of cannabis in its first full year in Canada, according to Canaccord Genuity analysts. (And that's just for recreational use.)
- Demand for medical cannabis is also growing at a significant pace, and the total combined demand for the first year could be 575,000 kilograms.
- Arcview Market Research of San-Francisco predicts that legal marijuana sales will reach close to $22 billion by 2021—up from nearly $7 billion last year. That's an annual growth rate of 26 percent, and it's in line with Deloitte's own estimations.
- In Canada alone, Canaccord Genuity predicts that the recreational marijuana industry could reach $6 billion in sales by 2021.
That's what happens when you end 'prohibition' for a market that is already huge—it's just hiding under the table. But this will blow away the billion-dollar industry that was reborn the moment alcohol prohibition ended on December 5, 1933.
Investors get it. That's why shares of medical marijuana producers more than tripled last year—just at the anticipation, and now that it is set to become legal, there is no telling what could happen.
- AXIM Biotechnologies (NASDAQOTH:AXIM): exploded 1,720 percent
- Corbus Pharmaceuticals (NASDAQ:CRBP) was up 431 percent
- Aphria (NASDAQOTH:APHQF) grew 381 percent
- Aurora Cannabis (NASDAQOTH:ACBFF) was up 299 percent
- Canopy Growth Corp. (NASDAQOTH:TWMJF) up 259 percent
- Medical Marijuana (NASDAQOTH:MJNA) up 254 percent
- GW Pharmaceuticals (NASDAQ:GWPH) was up 64 percent
In early April, Canada launched its first marijuana exchange-traded fund (ETF), giving investors diverse exposure to this tantalizing sector. The Horizons Medical Marijuana Life Sciences ETF (TSX:HMMJ) launched on the 4th of April on the Toronto Stock Exchange with 11 Canadian-listed stocks and four U.S.-listed stocks.
On 23 June, Invictus was included in the ETF.
Way Ahead of the Game, with a Massive Pot Pipeline
Invictus MD (TSX:IMH.V; OTC:IVITF) has multiple projects in its Canadian investment pipeline—all of them bolstered by some extremely savvy acquisitions. And they're not afraid of picks and shovels; they're all about hard work, if it's smart.
Prior to October, when it entered the license producer market, Invictus MD was busy acquiring all the 'picks and shovels' of the cannabis space. Invictus MD has made one smart move after another, and it's always the 'pick and shovel' guys who have real longevity. First, they acquired a fertilizer company that was cash-flow positive, and then they sold one of its lighting divisions for $5 million, having paid only $900,000 for it less than a year before. That's how they managed their first shareholder dividend.
They've been targeting small- and mid-size companies with significant growth potential and direct their strategies towards profitability. And this business savvy gives them everything they need to produce cheaply and to corner this market—but still maintain a valuation far below their peers. That why this is a very real entry point into this market for potential outsized gains.
The pipeline is impressive:
- 33% ownership in AB Laboratories Inc., which received its cultivation license in the third quarter of last year. A sales license is expected any day.
- The AB facility has a capacity for 1,000 kilograms, with active expansion plans underway.
- Invictus just closed its acquisition of 100 acres with AB Ventures Inc., and is targeting production here of 25,000 kilograms by 2020.
- In Alberta, Invictus owns 100% of Acreage Pharms, which has a license to cultivate under ACMPR and has a purpose built 7,000 square foot facility and a 30,000-square-foot phase 2 expansion plan with capital to expand an additional 75,000 square feet..
So, what we're looking at here is a wildly undervalued company that has an amazing set of assets and a pipeline to produce which is poised to explode onto a recreational market that is already bursting at the seams.
They Actually Pay Dividends. Need We Say More?
No one expects pot producers to pay dividends—yet. It's still early days, even with medical marijuana. Even so, Invictus has already rewarded its shareholders, to everyone's surprise. It was a Christmas bonus no one expected, and its speaks volumes about this company and its management.
In the words of Invictus Chairman and CEO, Dan Kriznic, "It made sense to give back to those who supported us."
Kriznic has been rated one of Business in Vancouver's 'Top 40 under 40', and he's put Invictus on the fast track to the market.
This CEO has turned $10-million companies into $150-million annual revenue generators. They've got a license to grow in more ways than one, and while they might not be a 'green giant' just yet, their undervaluation suggests they could be.
Why Invictus?
This company's not only rewarding shareholders early, but it's not afraid of hard work, and it has prime real estate for a cash crop that's going to keep growing.
- The company has a funded production capacity of about 18,000 kilograms. Compared to its peers, this suggests significant undervaluation.
- And not only are its strains pre-approved by the health authorities, but they will reach into every corner of the market. It's a marijuana octopus that has left no stone unturned.
- Invictus MD's market cap to funded capacity is about 5 times the industry standard.
This is the only door to walk through to the land of marijuana profits, but it won't be open much longer.
You can find out more on Invictus MD at the following links (TSX:IMH.V; OTC:IVITF)
Look...ya gotta get some of this.. http://www.prnewswire.com/news-releases/billionaires-bet-big-on-canadas-newest-22-billion-market-634982223.html
Billionaires Bet Big On Canada's Newest $22 Billion Market
NEWS PROVIDED BY
OilPrice.com
Jul 17, 2017, 13:15 ET
SHARE THIS ARTICLE
LONDON, July 17, 2017 /PRNewswire/ --
OilPrice.com News Commentary
The biggest multi-decade opportunity for investors right now is the Canadian government's legislation to legalize recreational marijuana by this time next year-and the first companies to win government approval will the high-risers. Active companies to watch include: GW Pharmaceuticals plc (NASDAQ: GWPH), INSYS Therapeutics, Inc. (NASDAQ: INSY), Zynerba Pharmaceuticals, Inc. (NASDAQ: ZYNE), AbbVie Inc. (NYSE: ABBV), Aphria Inc (OTC: APHQF) (TSX:APH.TO).
In a sector that's already seen stocks bust the borders with 1000% spikes, there is one company that currently has 2 of the only 50 licenses to cultivate in Canada, positioning itself to burst out of the gates as new legislation creates a multi-billion-dollar industry over night.
With one of the largest land packages to build cultivation facilities and 2 current licensed facilities located in two provinces in Canada, small-cap Invictus MD (IMH.V; IVITF) is set to rise.
It's already the first licensed medical marijuana company to pay a dividend to shareholders, and with its strains reaching into everything from pain management, cancer, epilepsy, anxiety and - most lucratively of all-recreation, the sky is the limit here.
We're now just shy of a year away from the start date of legal recreational use, and there are already predictions of a looming supply shortage.
Financial Post reports... there will soon be 3.8 million recreational users... But the market is only currently equipped to handle 150,000 medical marijuana patients.
The industry is scrambling to add growing capacity once the legal barriers are tossed aside.
Deloitte estimates this industry could be worth a whopping $22.6 billion annually. That's more than the combined sales of beer, wine and spirits.
Right out of the gate, Invictus MD, owner of two of just 50 licenses, has demonstrated that it will lead the way. The company holds $30 million in cash and is already generating dividends-a feat unheard of in the pot industry.
That's why it's called 'Canada's Cannabis Company'-it's already cemented market share for medical marijuana use, and now it's one of the first in and ready to fill the supply gap for a massive recreational push to supply 3.65 million new users.
Here are 5 Reasons to keep a close eye on Invictus MD (IMH.V; IVITF):
# 1 The Minting of the Next North American Billionaires
When you suddenly legalize a product that's already got a massive market under the table, you mint billionaires overnight. Just like it did at five o'clock on December 5, 1933-the moment Prohibition ended, and a billion-dollar industry (even then) was reborn.
It's already happening: The shares of the medical marijuana producers more than tripled last year, just at the prospects.
• AXIM Biotechnologies: exploded 1,720 percent
• Corbus Pharmaceuticals was up 431 percent
• Aphria grew 381 percent
• Aurora Cannabis was up 299 percent
• Canopy Growth Corp. up 259 percent
• Medical Marijuana up 254 percent
• GW Pharmaceuticals was up 64 percent
The smart money is investing too. Tribeca Investment Partners, a boutique fund manager, used bets on marijuana companies to help generate a 145 percent return over the year, according to Fortune magazine and Bloomberg. Nearly US$20 million of its investment gains in 2016 came from marijuana stocks, including Aurora Cannabis and Canopy Growth.
Then, in early April, Canada launched its first marijuana exchange-traded fund (ETF), giving investors diverse exposure to this tantalizing sector. The Horizons Medical Marijuana Life Sciences ETF launched on the 4th of April on the Toronto Stock Exchange with 11 Canadian-listed stocks and four U.S.-listed stocks.
On 23 June, Invictus was included in the ETF.
The frenzy surrounding Canada's marijuana market is palpable, and will be even more frenzied on 1 July 2018.
And Invictus is way ahead of this game: It's already got a license to produce in this multi-billion-dollar market.
#2 A Pot Pipeline Going in Every Direction
Invictus MD (IMH.V; IVITF) has multiple projects in its Canadian investment pipeline-all of them bolstered by some extremely savvy acquisitions.
The company's dream team targets small- and mid-size companies with significant growth potential and directs their strategies towards profitability.
They've made some game-changing acquisitions at just the right time; yet, their valuation is far below their peers, making Invictus a real entry point into this lucrative market if you're looking for outsized gains.
The company owns over 33 percent of AB Laboratories Inc., which received its cultivation license last October. The catalysts here are mounting, with the sales license expected in Q2. This facility has a capacity for 1,000 kilograms, with active expansion plans underway.
In May, Invictus also closed its acquisition of 100 acres with AB Ventures Inc., and is targeting production here of 25,000 kilograms by 2020.
In Alberta, Acreage Pharms received its license to cultivate under ACMPR and has a purpose built 7,000 square foot facility and a 30,000-square-foot expansion plan. Invictus MD currently owns 100 percent of this license.
It's a brilliant set-up for a small-cap company with CAD$30 million in cash and 78 million basic outstanding shares.
#3 Pot Dividends? The Impossible Because Reality
Invictus MD (IMH.V; IVITF)-made history in December by giving shareholders something they never expected to see in the marijuana industry in this decade: dividends.
The logic of Chairman and founder Dan Kriznic is one that shareholders will certainly appreciate: "It made sense to give back [to those] who supported us."
Not only have shareholders gotten dividends in an industry that generally hasn't been mature enough to pay out-yet-but there's a reason this company is a uniquely attractive entry point: Invictus MD's market cap to funded capacity is about 5 times the industry standard.
Right now, the company has a funded production capacity of about 18,000 kilograms which, compared to its peers, suggests Invictus MD is significantly undervalued.
Its smart acquisitions have made all the difference.
Prior to October, when it entered the license producer market, Invictus MD was busy acquiring all the 'picks and shovels' of the cannabis space. Invictus MD has made one smart move after another, and it's always the 'pick and shovel' guys who have real longevity. First, they acquired a fertilizer company that was cash-flow positive, and then they sold one of its lighting divisions for $5 million, having paid only $900,000 for it less than a year before.
They've been nurturing their shareholders along with their crops. Invictus MD's focus on two verticals-cannabis cultivation and cannabis fertilizer and nutrients-gives it a competitive, low-cost advantage on this playing field.
Now they've got prime real estate to add to their portfolio, and this is one cash crop that should keep growing.
#4 'Top 40 under 40' in Vancouver
There's a reason this company is positioned for great things. Kriznic has been rated one of Business in Vancouver's 'Top 40 under 40', and he's put Invictus on the fast track to the market. He has built over a billion dollars in value for shareholders in his past.
And not only are the strains pre-approved by the health authorities, but they will reach into every corner of this market. It's a marijuana octopus that has left no stone unturned.
Those strains include high THC strains used to help with pain management and cancer, and high-CBD strains used for epilepsy and anxiety disorders. And when it comes to recreational-the company is gearing up to work on all strains available.
This combined with its tight capitalization structure and access to capital could make this a prime breakout target over the coming weeks and months.
They're also not new to this game. Invictus MD isn't just jumping on the green train at the 11th hour; it has been laying the ground work for a very smart expansion strategy.
Kriznic has turned $10-million companies into $150-million annual revenue generators. They've got a license to grow in more ways than one, and while they might not be a 'green giant' just yet, their undervaluation suggests they could be.
#5 Massive Demand Just Waiting to Be Legalized
The fundamentals are clear-demand is set to further explode once recreational use of cannabis becomes legal.
Where does this leave us with supply? Playing some serious catch-up, which is a producer's dream. In Canada, legalizing recreational marijuana could result in demand of about 400,000 kilograms of cannabis in its first full year, according to Canaccord Genuity analysts. And that's just for recreational use. Demand for medical cannabis is also growing at a significant pace, and the total combined demand for the first year could be 575,000 kilograms.
Arcview Market Research of San-Francisco predicts that legal marijuana sales will reach close to $22 billion by 2021-up from nearly $7 billion last year. That's an annual growth rate of 26 percent, and it's in line with Deloitte's own estimations.
In Canada alone, Canaccord Genuity predicts that the recreational marijuana industry could reach $6 billion in sales by 2021.
If you haven't considered an entry point into this market yet-the window of opportunity is closing fast. Stocks are already shooting up on anticipation, and by 1 July 2018, high valuations will slam doors shut and only billionaires will come out. By that time, Invictus MD (IMH.V; IVITF) should already be walking with the green giants.
Canadian Cannabis Valuations up 200% in two years
250 acres of cultivation space stretching from Alberta to Ontario
Paid out $1,000,000 in Dividends representing $0.07 per Share
It might just be that Invictus MD Strategies Corp. (OTC: IVITF) (TSX.V: IMH) (FRA: 8IS) has adopted as a motto the elevating penultimate line from William Ernest Henley’s immortal poem Invictus: “I am the master of my fate”. Canada’s Cannabis Company appears completely unafraid as it ploughs ahead with its strategy to become a dominant company in Canada’s cannabis space. That boldness is paying off; Invictus is one of only a handful of cannabis companies declaring dividends. Now, with 250 acres of cultivation space stretching from Alberta to Ontario under management, Invictus is poised to deliver product to Canada’s medical and recreational marijuana markets, as Ottawa reiterates its determination to implement a legal framework for adult use by July 2018 (http://nnw.fm/a9CPC).
In executing that market domination strategy, Invictus’s management has pulled off some savvy deals since the company went public, under the symbol IMH, on the Canadian Securities Exchange (CSE) in December 2014. In March 2015, Invictus took up a 20 percent stake in hydroponic service company Future Harvest Development (FHD). Just four months later, it quickly increased that investment to acquire a majority holding and then sold off FHD’s Sunblaster Lighting division in February 2016. Those breathtaking developments provided a 216% return on investment; Sunblaster, sold for $2,850,000, had an acquisition cost of $900,000. Invictus now holds 82.5% of FHD.
Cannabis Health Sciences was another successful exit. The company, which publishes the Cannabis Health Journal, was bought for $45,000 and later sold for $230,000, earning Invictus a hefty return of 411 percent.
Invictus’ current portfolio companies have equal potential. Wholly-owned Acreage Farms of West-Central Alberta is currently valued at $34.5 million. The division received its cultivation license under the Access to Cannabis for Medical Purposes Regulations (ACMPR) on March 29, 2017, and is already operational. A 6,800 sq ft purpose built concrete and steel facility has already been constructed, and a planned expansion of 27,400 sq ft on the 150-acre property is imminent. Cultivation started in May 2017, and the unit is expected to reach output of 3,000 kg in 2018, 10,000 kg in 2019 and 25,000 kg by 2020.
In addition, together, associated companies AB Laboratories and AB Ventures are likely to do even better. Their joint production capacity is planned, by 2018, to hit 5,000 kg before climbing to 15,000 kg in 2019 and a level of 25,000 kg in 2020. AB Laboratories already has a cultivation license, received on October 21, 2016. The company, in which Invictus has a one-third stake, expects to get its sales license very soon and is currently valued at $30 million. Its facility in Hamilton, Ontario, covers about 16,000 sq ft.
AB Ventures is Invictus’s “startup” operation. The division closed a 100-acre acquisition in May 2017 and has filed an ACMPR pre-license application for that planned facility. It is aiming to develop 100,000 sq ft (about 2¼ acres) of cultivation and production space by 2019. The unit, in which Invictus also has a one-third stake, is valued at $22.5 million.
There is no doubt that halcyon days are ahead for Invictus. Valuations of cannabis companies have risen over 200 percent over the past two years, with some high fliers crossing the 300% mark. Valuations of ancillary businesses, those that supply services and equipment to the cannabis industry, are rising on the swell, too. Invictus was able to pay out a $1 million dividend to shareholders on December 5, 2016, representing $0.07 per share, because of its divestment of Sunblaster Lighting. With the Canadian recreational cannabis market projected to reach $6 billion, Invictus, now listed on the TSX-V under the symbol IMH, has a fate that looks decidedly promising.
Oh yeah...and K2 is done dumping. Bullish...
I gotta admit...can't seem to find anything wrong with this company. Decent float, 30 million cash on hand. Great acreage for expansion. They actually gave money back to investors in the form of a dividend. Fertilizer business that makes money. Upcoming first harvests in August. Approved licenses for medical weed. A shortage of weed nationwide in Canada. Nationwide legalization on the horizon for Canada, strong management team with fantastic track records...I like. I am in.....
GLTA
DD Links for Noobs:
https://www.reuters.com/finance/stocks/IDXG.O/key-developments
https://fintel.io/so/us/idxg
http://www.interpacediagnostics.com/investors/
http://www.nasdaq.com/symbol/idxg/sec-filings
This stock is starting to generate positive earnings in a worldwide $62 billion dollar industry. Do your research and get on board.
Best of luck...
I know it sucks when the rinse and repeat cycle presents itself again and again. But ya gotta understand that stock is created for one reason and one reason only. You print stock to sell for money to fund company operations. You only hope that the burn rate doesn't exceed profitability. This company just posted the best quarterly it has ever had. Recent buy in by the Armistice Hedge Fund locked up yet more shares. Vanguard holds this stock, Morgan Stanley, Goldman Sachs, JP Morgan Chase etc.. They just posted positive earnings: https://www.reuters.com/finance/stocks/IDXG.O/key-developments/article/3593784 I wouldn't quit on this company yet. Newbies go here and catch up: https://www.reuters.com/finance/stocks/IDXG.O/key-developments
Good luck to all...
Traders are like sheep...they will run together off a cliff if you scare them in the right direction. They will invest in pure air if you issue enough of the right "pump phrases"....even tons of excellent DD is no guarantee to a successful pick. But it helps way more than a freaking chart....
Cup and handle, head and shoulders chart patterns LMAO...
https://steemit.com/psychology/@kyriacos/why-technical-analysis-in-trading-is-100-bullshit
Charts are useful in reviewing the history of a stock. Nothing more than that....